The “HPAPI and Cytotoxic Drugs Manufacturing Market 2021-2030” report features an extensive study of the current market landscape, offering an informed opinion on the manufacturing of HPAPIs and cytotoxic drugs over the next decade. Close to 120 companies across the globe claim to possess the required expertise and infrastructure to offer contract manufacturing services for...

Manufacturing highly potent drug products is technically and financially demanding; as a result, drug manufacturers are becoming increasingly reliant on contract service providers   Roots Analysis is pleased to announce the publication of its recent study, titled, “HPAPI and Cytotoxic Drugs Manufacturing (3rd Edition) 2020-2030.”   The report features an extensive study of...